As Seen In

As Seen In
Your Hair Could Hold The Secret To Mending Your Injured Tendon
7 years ago Jun 26, 2017
To read the full article as it appears on Pridenews.ca , click here (6/27/17)....
As Seen In
The Latest in Biocellular Regeneration
7 years ago Jun 19, 2017
To read the full article as it appears on TheAestheticChannel.com by Lisette Hilton, click here...
As Seen In
Pioneer in Both Biotech & Business Left Noteworthy Legacy
7 years ago Jun 08, 2017
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,...
As Seen In
Exclusive Interview with RepliCel Life Sciences President and CEO Lee Buckler
8 years ago Jun 07, 2017
To read the full article as it appears on SmarterAnalyst.com by Julie Lamb, click here....
As Seen In
Promise of Regenerative Medicine Already Upon Us
8 years ago Jun 05, 2017
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,...
As Seen In
RepliCel Life Sciences gets price target raise at Echelon Wealth Partners
8 years ago May 29, 2017
To read the full article as it appears on Cantech Letters by Nick Waddell, click...
As Seen In
Cell therapy: Scientific breakthrough treats signs of ageing
8 years ago May 16, 2017
To read the full article as it appears on Cosmetics design-asia.com by Natasha Spencer, click...
As Seen In
RepliCel, cell therapy companies ready to give you athletic immortality
8 years ago May 13, 2017
To read the full article as it appears on Metro News by Matt Burke, click...
As Seen In
RepliCel Developing Autologous Cell Therapies For Skin, Hair and Tendon Regeneration
8 years ago Apr 21, 2017
To read the full interview as it appears on MedicalResearch.com, click here. (4/22/17)
As Seen In
String of Positive Trial Results Boosts RepliCel’s Profile
8 years ago Apr 11, 2017
To read the full article as it appears on thelifesciencesreport.com, click here. (04/12/17)
As Seen In
RepliCel – Stem Cell Therapies Using Your Own Cells
8 years ago Apr 09, 2017
To listen to Podcast and View Transcript on Future Tech Podcast, click here
As Seen In
Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)
8 years ago Apr 06, 2017
To read the full study as it appears on ClinicalTrials.gov, click here. Source: Clinical Trials....
As Seen In
Podcast: Replicel Life Sciences CEO Lee Buckler on global expansion
8 years ago Feb 05, 2017
To listen to Podcast and View Transcript on Financial Post click here
As Seen In
Companies Flocking to Japan for Biotech Deals
8 years ago Jan 31, 2017
To read the full article as it appears on The Life Sciences Report, click here....
As Seen In
ESPN with Bill Daughtry
8 years ago Jan 27, 2017
Listen: http://www.espn.com/espnradio/newyork/play?id=18570324 (at the 1:38 mark)
As Seen In
RepliCel (RP.V) Should Benefit from Renewed Investor Focus, Sweeping Legislation on Cell Therapy
8 years ago Jan 23, 2017
View Article on Zacks Small Cap Research click here
As Seen In
Will 2017 be the year of Cell Therapies?
8 years ago Jan 19, 2017
To read the full article as it appears on The Huffington Post, click here. (1/20/17)While...
As Seen In
Emerging Biotech Companies at Cantech 2017
8 years ago Jan 17, 2017
ProMIS Neurosciences, RepliCel Life Sciences, and Critical Outcome Technologies take the stageView Article by Pia...
As Seen In
RepliCel – Using Cells for Healing
8 years ago Jan 15, 2017
View featured company Article on Advisor Access click here
As Seen In
RepliCel CEO Lee Buckler talks to Cantech Letter
8 years ago Jan 10, 2017
View Article by Nick Waddell on Cantech Letter click here (1/11/2017)...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.